Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19

Addie B. Spier, Colin E. Evans*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The 2019–2020 COVID-19 outbreak resulted in widespread suffering along with major changes in the ways that researchers carry out their work. This article profiles the experiences of an early-career investigator in thrombosis research who worked through the COVID-19 pandemic and a COVID-19 diagnosis. The aims of this article are to normalize concern regarding COVID-19 in the research community, to provide a perspective on maintaining productivity during stay-at-home periods, and to discuss how the COVID-19 pandemic might alter common research practices in the future. While the COVID-19 outbreak was clearly disruptive and debilitating on a global level, some research practices that were heavily employed during the pandemic may continue to be utilized in scientific research for many years to come.

Original languageEnglish (US)
Article number100028
JournalThrombosis Update
Volume2
DOIs
StatePublished - Jan 2021

Funding

My PhD training at King’s College London provided me with a solid foundation in thrombosis research and triggered my interest in inflammatory vascular diseases [ 15–20 ]. During my postdoctoral training at the University of Cambridge, I received start-up grants from the British Heart Foundation and the British Society for Haematology to develop my research ideas and study the bi-directional interactions between lung tumorigenesis and thrombosis [ 21 , 22 ]. During my subsequent Parke Davis Fellowship at the University of Illinois College of Medicine, I began to assess how pulmonary thrombosis regulates the progression of acute lung injury [ 23 ]. As a Research Assistant Professor, I am currently continuing these studies at Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine, funded by a Career Development Award from the American Heart Association. C.E.E. is supported in part by an American Heart Association Career Development Award ( 19CDA34500000 ). A.B.S. wrote the clinical perspective and revised the manuscript. C.E.E. wrote and revised the manuscript.

Keywords

  • COVID-19
  • Research
  • Sepsis

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19'. Together they form a unique fingerprint.

Cite this